Skip to content
AnalystLens

Williams-Sonoma Annual Report (Amendment), Year Ended Feb 2, 2003

Filing Date
Filed April 16, 2003
Period End
February 2, 2003
Security
WSM
In the record · 2016–202610-K1110-Q328-K84

WSM filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 84 current reports (8-K) between 2016 and 2026.

  1. FY2017 annual report10-K · Mar ’17Mar ’17
  2. Leadership change8-K · Jul ’19Jul ’19
  3. Leadership change8-K · Aug ’21Aug ’21
  4. Material agreement8-K · Jun ’25Jun ’25

Summary

Summary of the 10-K/A filed April 16, 2003. Cited figures are marked; the original filing is the authoritative source.

This Form 10-K/A, Amendment No. 1, is filed by Williams-Sonoma, Inc. for the fiscal year ended February 2, 2003.

Its stated purpose is solely to add Exhibit 21 (Subsidiaries) and Exhibit 23.1 (Independent Auditors' Consent) to the Original Form 10-K, which was filed on April 15, 2003. The filing states that these exhibits were inadvertently omitted by the filing agent during the edgarization process. The document is dated April 16, 2003 and is signed by Chief Executive Officer Edward A.

Mueller. The cover page reports an aggregate market value of voting stock held by non-affiliates of $1,892,878,584,a based on a closing price of $20.45 on August 4, 2002. As of March 31, 2003, 115,116,133 shares of Common Stock were outstanding, listed on the New York Stock Exchange.

The company is identified as an accelerated filer. The exhibit index points to the company's principal financing and governance arrangements, including the Second Amended and Restated Credit Agreement dated October 22, 2002 with Bank of America, N.A. as administrative agent, and several equity compensation and employment-related plans and agreements. Financial results and operating detail are contained in the Original Form 10-K rather than in this amendment.

Key Highlights

  1. Amendment No. 1 to the fiscal 2002 Form 10-K (fiscal year ended February 2, 2003), filed April 16, 2003, solely to add Exhibit 21 (Subsidiaries) and Exhibit 23.1 (Independent Auditors' Consent).
  2. The Original Form 10-K was filed April 15, 2003; the filing agent inadvertently omitted these two exhibits during edgarization.
  3. Non-affiliate market value of voting stock was $1,892,878,584 as of August 4, 2002, based on a closing price of $20.45.
  4. 115,116,133 shares of Common Stock were outstanding as of March 31, 2003, listed on the New York Stock Exchange.
  5. The company is an accelerated filer and reports that it has filed all required Exchange Act reports during the preceding 12 months.
  6. The exhibit index references a Second Amended and Restated Credit Agreement dated October 22, 2002, with Bank of America, N.A. as administrative agent.
  7. Exhibit index also lists management contracts and compensatory plans, including the Associate Stock Incentive Plan and several stock option plans.

Frequently Asked Questions

  1. Why was this amended 10-K filed?

    The filing states that Amendment No. 1 was filed solely to add Exhibits 21 (Subsidiaries) and 23.1 (Independent Auditors' Consent), which were inadvertently omitted from the Original Form 10-K filed April 15, 2003, by the company's filing agent during edgarization.

  2. What is the fiscal period covered by this filing?

    The annual report covers the fiscal year ended February 2, 2003, as stated on the cover page.

  3. How many shares were outstanding and what was the public float value?

    As of March 31, 2003, 115,116,133 shares of Common Stock were outstanding. The aggregate market value of voting stock held by non-affiliates was $1,892,878,584 as of August 4, 2002, using a closing price of $20.45.

  4. Which credit facility is referenced in the exhibit index?

    The exhibit index lists a Second Amended and Restated Credit Agreement dated October 22, 2002, between the company and Bank of America, N.A. as administrative agent and L/C issuer, with Fleet National Bank and The Bank of New York as co-syndication agents, and Wells Fargo Bank, N.A. and JPMorgan Chase Bank as co-documentation agents.